Category: 2024,No. 01

Progress in programmed cell death of RPE cells in age-related macular degeneration

Authors: Jing Qinghe,  Kong Hongyu,  Zhao Chen DOI: 10.3760/cma.j.cn115989-20210322-00196 Published 2024-01-10 Cite as Chin J Exp Ophthalmol, 2024, 42(1): 80-85. Abstract                              [Download PDF] [Read Full Text] Age-related macular degeneration (AMD) is a leading cause of blindness in the elderly worldwide and is […]

Strategies to improve functional integration of transplanted photoreceptors

Authors: Wang Jun,  Chen Yiqi,  Shen Lijun DOI: 10.3760/cma.j.cn115989-20200512-00342 Published 2024-01-10 Cite as Chin J Exp Ophthalmol, 2024, 42(1): 86-91. Abstract                              [Download PDF] [Read Full Text] The final outcome of the retinal degenerative diseases is the massive loss of photoreceptors, resulting in […]

Effect and significance of secretogranin Ⅲ in diabetic retinal neovascularization

Authors: Wang Manqiao,  Li Xiaorong DOI: 10.3760/cma.j.cn115989-20201012-00688 Published 2024-01-10 Cite as Chin J Exp Ophthalmol, 2024, 42(1): 93-96. Abstract                              [Download PDF] [Read Full Text] Secretogranin Ⅲ (SCG3) is a kind of secretory granule widely distributed in tissues and cells with endocrine functions […]

Diagnosis and treatment of orbital invasive fibromatosis: a case report

Authors: Wang Nan,  Liu Rui,  Luan Fuxiao,  Ge Xin,  Ma Jianmin DOI: 10.3760/cma.j.cn115989-20200718-00511 Published 2024-01-10 Cite as Chin J Exp Ophthalmol, 2024, 42(1): 91-92. [Download PDF] [Read Full Text] Contributor Information Wang Nan Ophthalmological Oncology Department, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Ophthalmology and Visual Sciences Key Laboratory, Beijing 100730, China Liu Rui […]